{"hands_on_practices": [{"introduction": "A cornerstone technique for studying immunometabolism is extracellular flux analysis, which measures a cell's oxygen consumption rate ($OCR$) and extracellular acidification rate ($ECAR$) in real-time. By sequentially adding specific metabolic inhibitors, we can dissect the various components of cellular respiration. This practice will guide you through the essential process of converting raw experimental data into key bioenergetic parameters, a fundamental skill for characterizing the metabolic phenotype of macrophages and other myeloid cells [@problem_id:2860411].", "problem": "A human monocyte-derived macrophage culture is profiled on an extracellular flux analyzer to quantify immunometabolic respiration parameters under sequential drug injections. Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) are recorded in triplicate measurement cycles at each condition. Instrumental background contributes a constant offset that must be subtracted from all raw readings. Cell number per well is determined for normalization.\n\nFundamental definitions and facts to use:\n- OCR reflects mitochondrial and non-mitochondrial oxygen consumption; background must be subtracted before biological interpretation.\n- Oligomycin inhibits the adenosine triphosphate (ATP) synthase, acutely reducing the ATP-coupled component of mitochondrial respiration and revealing proton leak plus non-mitochondrial oxygen consumption.\n- Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) is a protonophore that uncouples the mitochondrial membrane potential, driving the electron transport chain to its maximal capacity.\n- Non-mitochondrial respiration is estimated from measurements in the presence of inhibitors of Complex I and III; it is subtracted to isolate mitochondrial components.\n\nData provided for a single well:\n- Instrumental background OCR: $5.0$ pmol $\\mathrm{O_{2}}$ min$^{-1}$.\n- Cell number per well: $0.80 \\times 10^{6}$ cells (normalize all OCR to per $10^{6}$ cells).\n- OCR (pmol $\\mathrm{O_{2}}$ min$^{-1}$) triplicates:\n  1. Baseline (pre-drug): $118$, $122$, $120$.\n  2. After oligomycin: $79$, $81$, $80$.\n  3. After FCCP: $216$, $222$, $222$.\n- Separately measured non-mitochondrial OCR (after rotenone plus antimycin A in a matched well with the same cell number): $30$, $32$, $28$ pmol $\\mathrm{O_{2}}$ min$^{-1}$.\n- ECAR (mpH min$^{-1}$) triplicates for context (not required in the requested calculations): Baseline $40$, $42$, $41$; after oligomycin $75$, $77$, $76$; after FCCP $50$, $52$, $51$. Instrumental background ECAR: $1.0$ mpH min$^{-1}$.\n\nUsing only the principled definitions above and the provided data, compute the following mitochondrial respiration parameters, each background-corrected and normalized to per $10^{6}$ cells:\n- Basal respiration: baseline OCR minus non-mitochondrial OCR.\n- ATP-linked respiration: decrease in OCR upon oligomycin addition relative to baseline.\n- Spare respiratory capacity: increase in OCR upon FCCP relative to baseline.\n\nInstructions:\n- For each condition, first average the triplicates, subtract the instrumental background from the mean, and then normalize by the cell number to express in pmol $\\mathrm{O_{2}}$ min$^{-1}$ per $10^{6}$ cells.\n- Round your final results to four significant figures.\n- Express all oxygen consumption values in pmol $\\mathrm{O_{2}}$ min$^{-1}$ per $10^{6}$ cells.\n- Provide your final answer as a row matrix in the order: basal respiration, ATP-linked respiration, spare respiratory capacity.", "solution": "We begin from definitions standard to extracellular flux analysis of macrophage immunometabolism.\n\nLet the mean raw Oxygen Consumption Rate (OCR) at baseline, after oligomycin, and after Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) be denoted by $O_{\\mathrm{base}}$, $O_{\\mathrm{oligo}}$, and $O_{\\mathrm{FCCP}}$, respectively, with instrumental background $b$. Let $c$ be the number of cells per well in units of $10^{6}$ cells, so normalization to per $10^{6}$ cells is achieved by division by $c$. Let the mean raw non-mitochondrial OCR (measured in the presence of rotenone plus antimycin A) be $O_{\\mathrm{nm,raw}}$.\n\nThe background-corrected, cell-normalized quantities are\n$$\n\\tilde{O}_{\\mathrm{base}} = \\frac{O_{\\mathrm{base}} - b}{c}, \\quad\n\\tilde{O}_{\\mathrm{oligo}} = \\frac{O_{\\mathrm{oligo}} - b}{c}, \\quad\n\\tilde{O}_{\\mathrm{FCCP}} = \\frac{O_{\\mathrm{FCCP}} - b}{c}, \\quad\n\\tilde{O}_{\\mathrm{nm}} = \\frac{O_{\\mathrm{nm,raw}} - b}{c}.\n$$\n\nBy definition:\n- Basal mitochondrial respiration is the baseline mitochondrial OCR, computed as baseline minus non-mitochondrial:\n$$\nR_{\\mathrm{basal}} = \\tilde{O}_{\\mathrm{base}} - \\tilde{O}_{\\mathrm{nm}}.\n$$\n- Adenosine triphosphate (ATP)-linked respiration is the drop upon ATP synthase inhibition:\n$$\nR_{\\mathrm{ATP}} = \\tilde{O}_{\\mathrm{base}} - \\tilde{O}_{\\mathrm{oligo}}.\n$$\nNote that non-mitochondrial respiration is present in both terms and cancels in the difference.\n- Spare respiratory capacity is the increase from baseline to uncoupled maximal respiration:\n$$\nR_{\\mathrm{spare}} = \\tilde{O}_{\\mathrm{FCCP}} - \\tilde{O}_{\\mathrm{base}}.\n$$\nAgain, non-mitochondrial respiration cancels if it is unchanged across conditions, as assumed.\n\nNow compute means, apply background subtraction, and normalize.\n\nGiven triplicates:\n- Baseline mean:\n$$\nO_{\\mathrm{base}} = \\frac{118 + 122 + 120}{3} = \\frac{360}{3} = 120.\n$$\n- Oligomycin mean:\n$$\nO_{\\mathrm{oligo}} = \\frac{79 + 81 + 80}{3} = \\frac{240}{3} = 80.\n$$\n- FCCP mean:\n$$\nO_{\\mathrm{FCCP}} = \\frac{216 + 222 + 222}{3} = \\frac{660}{3} = 220.\n$$\n- Non-mitochondrial mean:\n$$\nO_{\\mathrm{nm,raw}} = \\frac{30 + 32 + 28}{3} = \\frac{90}{3} = 30.\n$$\n\nInstrumental background is $b = 5.0$. Cell number per well is $c = 0.80$ (in units of $10^{6}$ cells).\n\nBackground-corrected, normalized OCRs:\n$$\n\\tilde{O}_{\\mathrm{base}} = \\frac{120 - 5}{0.80} = \\frac{115}{0.80} = 143.75,\n$$\n$$\n\\tilde{O}_{\\mathrm{oligo}} = \\frac{80 - 5}{0.80} = \\frac{75}{0.80} = 93.75,\n$$\n$$\n\\tilde{O}_{\\mathrm{FCCP}} = \\frac{220 - 5}{0.80} = \\frac{215}{0.80} = 268.75,\n$$\n$$\n\\tilde{O}_{\\mathrm{nm}} = \\frac{30 - 5}{0.80} = \\frac{25}{0.80} = 31.25.\n$$\n\nNow compute the requested parameters:\n- Basal respiration:\n$$\nR_{\\mathrm{basal}} = 143.75 - 31.25 = 112.5.\n$$\n- ATP-linked respiration:\n$$\nR_{\\mathrm{ATP}} = 143.75 - 93.75 = 50.0.\n$$\n- Spare respiratory capacity:\n$$\nR_{\\mathrm{spare}} = 268.75 - 143.75 = 125.0.\n$$\n\nAll values are in pmol $\\mathrm{O_{2}}$ min$^{-1}$ per $10^{6}$ cells. Rounding each to four significant figures gives $112.5$, $50.00$, and $125.0$, respectively. The ECAR data, while consistent with an oligomycin-induced shift toward glycolysis and a distinct FCCP response, are not required for these three OCR-based calculations.", "answer": "$$\\boxed{\\begin{pmatrix}112.5 & 50.00 & 125.0\\end{pmatrix}}$$", "id": "2860411"}, {"introduction": "In addition to mitochondrial respiration, macrophages—especially those classically activated by signals like lipopolysaccharide ($LPS$)—dramatically increase their rate of glycolysis, a phenomenon often called aerobic glycolysis. This metabolic shift is characterized by high glucose uptake and lactate secretion. This exercise demonstrates how to quantify the net glycolytic flux and the efficiency of lactate production from basic measurements of extracellular metabolite concentrations, providing a direct window into this critical aspect of macrophage activation [@problem_id:2860446].", "problem": "A culture of bone marrow–derived macrophages is stimulated with lipopolysaccharide (LPS). You plate $N = 1.00 \\times 10^{6}$ cells in a well containing a total medium volume of $V = 2.00\\,\\mathrm{mL}$. Over a period of $120\\,\\mathrm{min}$, you monitor extracellular glucose and lactate concentrations at $t = 0, 30, 60, 90, 120\\,\\mathrm{min}$. A matched cell-free control shows negligible drift (absolute change $< 0.005\\,\\mathrm{mM}$ for both analytes) over the same interval and can be ignored. Assume the medium volume is constant, cell number is constant, extracellular changes arise solely from cellular uptake or secretion, and extracellular lactate originates from glycolytically produced pyruvate via lactate dehydrogenase.\n\nMeasured concentrations in the macrophage-containing well (all in $\\mathrm{mM}$):\n- Glucose: $10.00$ at $0\\,\\mathrm{min}$; $9.92$ at $30\\,\\mathrm{min}$; $9.84$ at $60\\,\\mathrm{min}$; $9.76$ at $90\\,\\mathrm{min}$; $9.68$ at $120\\,\\mathrm{min}$.\n- Lactate: $1.00$ at $0\\,\\mathrm{min}$; $1.12$ at $30\\,\\mathrm{min}$; $1.24$ at $60\\,\\mathrm{min}$; $1.36$ at $90\\,\\mathrm{min}$; $1.48$ at $120\\,\\mathrm{min}$.\n\nUsing conservation of mass and the stoichiometry of glycolysis (one glucose yields two pyruvate, which can yield two lactate), and assuming the concentration changes are linear over the $0$ to $120\\,\\mathrm{min}$ interval, do the following:\n- Compute the net glycolytic flux per cell, defined operationally here as the rate of glucose consumption per cell derived from extracellular glucose disappearance over time.\n- Compute the lactate yield per glucose, defined as the ratio of the per-cell lactate secretion rate to the per-cell glucose consumption rate over the same interval.\n\nExpress the net glycolytic flux in $\\mathrm{fmol}\\,\\mathrm{cell}^{-1}\\,\\mathrm{min}^{-1}$ and the lactate yield per glucose as a unitless decimal. Round both reported values to three significant figures. Provide the two values in the order specified.", "solution": "The problem statement is parsed and validated. It is found to be scientifically grounded, describing a standard experimental procedure in cellular metabolism. The data provided are consistent, and the assumptions, such as linearity of concentration changes, are explicitly stated. The problem is well-posed and contains all necessary information for a unique, verifiable solution. We will therefore proceed with the calculation.\n\nThe task is to compute two quantities: the net glycolytic flux per cell, which we will denote as $J_G$, and the lactate yield per glucose, denoted as $Y_{L/G}$.\n\nFirst, we calculate the net glycolytic flux, $J_G$. This is defined as the rate of glucose consumption per cell. The data for glucose concentration, $[G]$, are given at multiple time points. The problem states to assume a linear change over the interval from $t=0$ to $t=120\\,\\mathrm{min}$. Therefore, the rate of change of glucose concentration is constant and can be calculated using the initial and final points.\n\nThe change in glucose concentration is:\n$$ \\Delta [G] = [G]_{t=120} - [G]_{t=0} = 9.68\\,\\mathrm{mM} - 10.00\\,\\mathrm{mM} = -0.32\\,\\mathrm{mM} $$\nThe time interval is:\n$$ \\Delta t = 120\\,\\mathrm{min} - 0\\,\\mathrm{min} = 120\\,\\mathrm{min} $$\nThe rate of change of glucose concentration in the medium is:\n$$ \\frac{d[G]}{dt} = \\frac{\\Delta [G]}{\\Delta t} = \\frac{-0.32\\,\\mathrm{mM}}{120\\,\\mathrm{min}} $$\nThe rate of glucose consumption from the medium, $R_G$, is the negative of this value:\n$$ R_G = - \\frac{d[G]}{dt} = \\frac{0.32\\,\\mathrm{mM}}{120\\,\\mathrm{min}} $$\nTo find the total molar rate of glucose consumption for the entire cell population, we multiply this concentration rate by the medium volume, $V = 2.00\\,\\mathrm{mL}$. We must perform unit conversion for consistency.\n$$ 1\\,\\mathrm{mM} = 10^{-3}\\,\\mathrm{mol}\\,\\mathrm{L}^{-1} $$\n$$ 1\\,\\mathrm{mL} = 10^{-3}\\,\\mathrm{L} $$\nThe total molar rate of glucose consumption, $\\frac{dn_G}{dt}$, is:\n$$ \\frac{dn_G}{dt} = R_G \\times V = \\left( \\frac{0.32}{120} \\frac{\\mathrm{mmol}}{\\mathrm{L} \\cdot \\mathrm{min}} \\right) \\times (2.00\\,\\mathrm{mL}) = \\left( \\frac{0.32}{120} \\frac{10^{-3}\\,\\mathrm{mol}}{\\mathrm{L} \\cdot \\mathrm{min}} \\right) \\times (2.00 \\times 10^{-3}\\,\\mathrm{L}) $$\n$$ \\frac{dn_G}{dt} = \\frac{0.32 \\times 2.00 \\times 10^{-6}}{120} \\, \\frac{\\mathrm{mol}}{\\mathrm{min}} = \\frac{0.64 \\times 10^{-6}}{120} \\, \\frac{\\mathrm{mol}}{\\mathrm{min}} $$\nThis rate corresponds to the total number of cells, $N = 1.00 \\times 10^{6}$. The flux per cell, $J_G$, is obtained by dividing the total rate by the number of cells:\n$$ J_G = \\frac{1}{N} \\frac{dn_G}{dt} = \\frac{1}{1.00 \\times 10^{6}\\,\\mathrm{cells}} \\left( \\frac{0.64 \\times 10^{-6}}{120} \\, \\frac{\\mathrm{mol}}{\\mathrm{min}} \\right) $$\n$$ J_G = \\frac{0.64}{120 \\times 1.00} \\times 10^{-12} \\, \\frac{\\mathrm{mol}}{\\mathrm{cell} \\cdot \\mathrm{min}} \\approx 5.333... \\times 10^{-15} \\, \\frac{\\mathrm{mol}}{\\mathrm{cell} \\cdot \\mathrm{min}} $$\nThe problem requires the result in units of femomoles per cell per minute ($\\mathrm{fmol}\\,\\mathrm{cell}^{-1}\\,\\mathrm{min}^{-1}$). Since $1\\,\\mathrm{fmol} = 10^{-15}\\,\\mathrm{mol}$:\n$$ J_G = 5.333... \\, \\frac{\\mathrm{fmol}}{\\mathrm{cell} \\cdot \\mathrm{min}} $$\nRounding to three significant figures, we get:\n$$ J_G \\approx 5.33\\,\\mathrm{fmol}\\,\\mathrm{cell}^{-1}\\,\\mathrm{min}^{-1} $$\n\nSecond, we compute the lactate yield per glucose, $Y_{L/G}$. This is defined as the ratio of the per-cell lactate secretion rate, $J_L$, to the per-cell glucose consumption rate, $J_G$.\n$$ Y_{L/G} = \\frac{J_L}{J_G} $$\nThe rates $J_L$ and $J_G$ are calculated using the same volume $V$ and cell number $N$. The ratio can therefore be simplified to the ratio of the absolute values of the concentration change rates:\n$$ Y_{L/G} = \\frac{ \\frac{1}{N} \\left( \\frac{d[L]}{dt} \\times V \\right) }{ \\frac{1}{N} \\left( \\left(-\\frac{d[G]}{dt}\\right) \\times V \\right) } = \\frac{ \\frac{d[L]}{dt} }{ -\\frac{d[G]}{dt} } $$\nFirst, we find the rate of change of lactate concentration, $\\frac{d[L]}{dt}$. The data are linear.\n$$ \\Delta [L] = [L]_{t=120} - [L]_{t=0} = 1.48\\,\\mathrm{mM} - 1.00\\,\\mathrm{mM} = 0.48\\,\\mathrm{mM} $$\n$$ \\frac{d[L]}{dt} = \\frac{\\Delta [L]}{\\Delta t} = \\frac{0.48\\,\\mathrm{mM}}{120\\,\\mathrm{min}} $$\nThe rate of glucose consumption, in terms of concentration change, was previously found to be $R_G = -\\frac{d[G]}{dt} = \\frac{0.32\\,\\mathrm{mM}}{120\\,\\mathrm{min}}$.\nNow we compute the ratio:\n$$ Y_{L/G} = \\frac{\\frac{0.48\\,\\mathrm{mM}}{120\\,\\mathrm{min}}}{\\frac{0.32\\,\\mathrm{mM}}{120\\,\\mathrm{min}}} = \\frac{0.48}{0.32} = \\frac{3 \\times 0.16}{2 \\times 0.16} = \\frac{3}{2} = 1.5 $$\nThe result is a unitless ratio. Rounding to three significant figures as requested gives $1.50$. This value indicates that for every $2$ moles of glucose consumed by the cells from the medium, $3$ moles of lactate are secreted. This is consistent with the biochemical stoichiometry of glycolysis where the theoretical maximum yield is $2$ moles of lactate per mole of glucose, as some consumed glucose may be directed to other metabolic pathways.", "answer": "$$\n\\boxed{\\begin{pmatrix} 5.33 & 1.50 \\end{pmatrix}}\n$$", "id": "2860446"}, {"introduction": "Macrophage polarization into distinct functional subtypes, such as pro-inflammatory $\\text{M(IFN-}\\gamma\\text{+LPS)}$ or anti-inflammatory $\\text{M(IL-4)}$ cells, is underpinned by profound metabolic reprogramming. Stable isotope tracing, using nutrients labeled with heavy isotopes like $^{13}\\mathrm{C}$, is a powerful method to map these altered metabolic routes. This conceptual exercise challenges you to apply your knowledge of macrophage metabolism to predict the outcome of a $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$ tracing experiment, highlighting the differential wiring of the tricarboxylic acid (TCA) cycle in these two key activation states [@problem_id:2860398].", "problem": "A research group polarizes primary bone marrow-derived macrophages either with Interleukin-4 (IL-4) to generate alternatively activated macrophages, denoted $\\text{M(IL-4)}$, or with Interferon gamma (IFN-$\\gamma$) plus lipopolysaccharide (LPS) to generate classically activated macrophages, denoted $\\text{M(IFN-}\\gamma\\text{+LPS)}$. Cells are acutely pulsed with uniformly labeled glutamine, $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$, in the presence of unlabeled glucose and an unlabeled bicarbonate/carbon dioxide pool. After a short labeling period intended to capture first-pass carbon flow, isotopologue distributions in citrate and malate are quantified by mass spectrometry. The notation $\\mathrm{M{+}x}$ indicates that a metabolite contains $x$ carbons derived from $\\mathrm{^{13}C}$.\n\nUsing only well-established facts that (i) uniformly labeled glutamine enters the tricarboxylic acid (TCA) cycle through glutaminolysis as labeled $\\alpha$-ketoglutarate, (ii) tricarboxylic acid cycle oxidative flux converts $\\alpha$-ketoglutarate to downstream $4$-carbon dicarboxylates, and (iii) reductive carboxylation converts $\\alpha$-ketoglutarate to citrate by consuming carbon dioxide, and assuming that acetyl-coenzyme A contributing to citrate synthesis is unlabeled under these conditions, which option best predicts the predominant isotopologues observed for citrate and malate in $\\text{M(IL-4)}$ versus $\\text{M(IFN-}\\gamma\\text{+LPS)}$?\n\nA. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}5}$, malate $\\mathrm{M{+}3}$\n\nB. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}5}$, malate $\\mathrm{M{+}3}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$\n\nC. Both $\\text{M(IL-4)}$ and $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$\n\nD. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}2}$, malate $\\mathrm{M{+}2}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}6}$, malate $\\mathrm{M{+}5}$", "solution": "The problem statement is subjected to validation.\n\n### Step 1: Extract Givens\n-   Cell types: Primary bone marrow-derived macrophages.\n-   Polarization conditions:\n    1.  Alternatively activated macrophages, denoted $\\text{M(IL-4)}$, are generated with Interleukin-4 (IL-4).\n    2.  Classically activated macrophages, denoted $\\text{M(IFN-}\\gamma\\text{+LPS)}$, are generated with Interferon gamma (IFN-$\\gamma$) plus lipopolysaccharide (LPS).\n-   Tracer: Uniformly labeled glutamine, $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$.\n-   Background media: Unlabeled glucose and an unlabeled bicarbonate/carbon dioxide ($\\mathrm{CO_2}$) pool.\n-   Experimental condition: Acute pulse labeling to measure first-pass carbon flow.\n-   Measurements: Isotopologue distributions in citrate and malate.\n-   Notation: $\\mathrm{M{+}x}$ signifies a metabolite with $x$ carbons labeled with $^{13}\\mathrm{C}$.\n-   Fact (i): $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$ enters the tricarboxylic acid (TCA) cycle via glutaminolysis as labeled $\\alpha$-ketoglutarate.\n-   Fact (ii): Oxidative TCA cycle flux converts $\\alpha$-ketoglutarate to downstream $4$-carbon dicarboxylates.\n-   Fact (iii): Reductive carboxylation converts $\\alpha$-ketoglutarate to citrate by consuming carbon dioxide.\n-   Assumption: Acetyl–coenzyme A (acetyl-CoA) is unlabeled.\n\n### Step 2: Validate Using Extracted Givens\nThe problem describes a standard stable isotope tracing experiment to probe the metabolic differences between M1-like ($\\text{M(IFN-}\\gamma\\text{+LPS)}$) and M2-like ($\\text{M(IL-4)}$) macrophages, a central topic in the field of immunometabolism.\n-   **Scientifically Grounded**: The premises are correct. Macrophage polarization by IL-4 and IFN-$\\gamma$+LPS is a standard model. Glutaminolysis, the TCA cycle, and reductive carboxylation are fundamental metabolic pathways. The metabolic reprogramming of macrophages, particularly the enhanced reductive carboxylation in M1-like macrophages, is a well-established scientific fact. The assumption of unlabeled acetyl-CoA is reasonable for a short glutamine pulse, as acetyl-CoA is primarily derived from glucose (given as unlabeled) via glycolysis and the pyruvate dehydrogenase complex. The problem is scientifically sound.\n-   **Well-Posed**: The problem asks for the *predominant* isotopologues, which requires identifying the dominant metabolic flux in each cell type based on established biological principles and tracing the carbon atoms. This leads to a unique, meaningful solution.\n-   **Objective**: The problem is stated using precise, objective scientific language.\nThe problem is free of the invalidity flaws listed in the instructions. It is a well-formed problem in biochemistry and cell biology.\n\n### Step 3: Verdict and Action\nThe problem is valid. The solution will now be derived.\n\n### Derivation\nThe core of the problem is to trace the fate of the five $^{13}\\mathrm{C}$ atoms from $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$ through two distinct metabolic pathways originating from $\\alpha$-ketoglutarate (AKG).\n\n1.  **Metabolite Entry**: Glutamine is a $5$-carbon ($C_5$) amino acid. $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{glutamine}$ is thus glutamine $\\mathrm{M{+}5}$. Glutaminolysis converts it to glutamate ($\\mathrm{M{+}5}$) and then to AKG, which is also a $5$-carbon molecule. Therefore, the AKG entering the TCA cycle is $\\left[\\mathrm{U\\text{-}^{13}C}\\right]\\mathrm{AKG}$, or AKG $\\mathrm{M{+}5}$.\n\n2.  **Analysis of the Oxidative TCA Cycle Pathway**:\n    -   The oxidative pathway proceeds from AKG ($\\mathrm{M{+}5}$, $C_5$) in the canonical forward direction of the TCA cycle.\n    -   AKG ($\\mathrm{M{+}5}$) is oxidatively decarboxylated to succinyl-CoA by the AKG dehydrogenase complex. This reaction removes one carbon atom (as $\\mathrm{CO_2}$), which is one of the original $^{13}\\mathrm{C}$ atoms.\n    -   The resulting succinyl-CoA is a $4$-carbon ($C_4$) molecule and will contain $5-1=4$ labeled carbons, making it succinyl-CoA $\\mathrm{M{+}4}$.\n    -   Subsequent enzymatic steps convert succinyl-CoA $\\mathrm{M{+}4}$ to succinate $\\mathrm{M{+}4}$, then to fumarate $\\mathrm{M{+}4}$, and finally to malate $\\mathrm{M{+}4}$. Thus, the first-pass oxidative flux produces **malate $\\mathrm{M{+}4}$**.\n    -   To generate citrate via this pathway, malate $\\mathrm{M{+}4}$ is oxidized to oxaloacetate (OAA) $\\mathrm{M{+}4}$. This OAA($\\mathrm{M{+}4}$) then condenses with acetyl-CoA.\n    -   The problem states that acetyl-CoA is unlabeled, i.e., acetyl-CoA $\\mathrm{M{+}0}$.\n    -   The condensation reaction is: $\\text{OAA}(\\mathrm{M{+}4}) + \\text{Acetyl-CoA}(\\mathrm{M{+}0}) \\rightarrow \\text{Citrate}(\\mathrm{M{+}4})$. Thus, the oxidative pathway generates **citrate $\\mathrm{M{+}4}$**.\n\n3.  **Analysis of the Reductive Carboxylation Pathway**:\n    -   The reductive pathway proceeds from AKG in the reverse direction via a reductive carboxylation step catalyzed by isocitrate dehydrogenase (IDH).\n    -   AKG ($\\mathrm{M{+}5}$, $C_5$) reacts with a molecule of $\\mathrm{CO_2}$. The problem specifies an unlabeled $\\mathrm{CO_2}$ pool ($\\mathrm{M{+}0}$).\n    -   The reaction is: $\\text{AKG}(\\mathrm{M{+}5}) + \\mathrm{CO_2}(\\mathrm{M{+}0}) \\rightarrow \\text{Isocitrate}$. The product is a $6$-carbon ($C_6$) molecule containing the $5$ labeled carbons from AKG and $1$ unlabeled carbon from $\\mathrm{CO_2}$. This yields isocitrate $\\mathrm{M{+}5}$.\n    -   Isocitrate is readily isomerized to citrate by aconitase, without any change in carbon count or labeling. The resulting citrate is **citrate $\\mathrm{M{+}5}$**.\n    -   In cells with high reductive flux, this citrate $\\mathrm{M{+}5}$ is often exported to the cytosol and cleaved by ATP-citrate lyase (ACLY) into OAA and acetyl-CoA.\n    -   Due to the stereochemistry of the enzymes involved, the cleavage of citrate $\\mathrm{M{+}5}$ originating from AKG $\\mathrm{M{+}5}$ yields OAA $\\mathrm{M{+}3}$ and acetyl-CoA $\\mathrm{M{+}2}$.\n    -   This cytosolic OAA $\\mathrm{M{+}3}$ can be reduced by malate dehydrogenase (MDH) to malate. This reaction preserves the carbon backbone.\n    -   The resulting malate is **malate $\\mathrm{M{+}3}$**.\n\n4.  **Application to Macrophage Phenotypes**:\n    -   **$\\text{M(IL-4)}$ (Alternatively Activated/M2-like Macrophages)**: These macrophages are characterized by an intact, functional oxidative TCA cycle that supports oxidative phosphorylation for sustained energy production. They do not exhibit significant reductive carboxylation. Therefore, the predominant metabolic flux from glutamine will follow the **oxidative pathway**. Based on our analysis in point 2, we predict the predominant isotopologues will be **citrate $\\mathrm{M{+}4}$** and **malate $\\mathrm{M{+}4}$**.\n    -   **$\\text{M(IFN-}\\gamma\\text{+LPS)}$ (Classically Activated/M1-like Macrophages)**: These macrophages undergo significant metabolic reprogramming, featuring a \"broken\" TCA cycle with breaks at IDH and succinate dehydrogenase. To support the synthesis of inflammatory mediators and fatty acids, they depend heavily on glutamine and utilize **reductive carboxylation** to produce citrate. Therefore, the predominant metabolic flux from glutamine will follow the **reductive pathway**. Based on our analysis in point 3, we predict the predominant isotopologues will be **citrate $\\mathrm{M{+}5}$** and **malate $\\mathrm{M{+}3}$**.\n\n### Option-by-Option Analysis\n\n-   **A. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}5}$, malate $\\mathrm{M{+}3}$**\n    This option correctly assigns the metabolic signature of an oxidative TCA cycle (citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$) to $\\text{M(IL-4)}$ macrophages and the signature of reductive carboxylation (citrate $\\mathrm{M{+}5}$, malate $\\mathrm{M{+}3}$) to $\\text{M(IFN-}\\gamma\\text{+LPS)}$ macrophages. This matches our derivation precisely.\n    Verdict: **Correct**.\n\n-   **B. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}5}$, malate $\\mathrm{M{+}3}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$**\n    This option incorrectly reverses the metabolic phenotypes of the two macrophage subtypes. It attributes reductive carboxylation to $\\text{M(IL-4)}$ cells and an oxidative TCA cycle to $\\text{M(IFN-}\\gamma\\text{+LPS)}$ cells, which is contrary to established principles of immunometabolism.\n    Verdict: **Incorrect**.\n\n-   **C. Both $\\text{M(IL-4)}$ and $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}4}$, malate $\\mathrm{M{+}4}$**\n    This option suggests that both macrophage types have the same metabolic profile, dominated by the oxidative TCA cycle. This ignores the well-documented metabolic shift towards reductive carboxylation in classically activated macrophages.\n    Verdict: **Incorrect**.\n\n-   **D. $\\text{M(IL-4)}$: citrate $\\mathrm{M{+}2}$, malate $\\mathrm{M{+}2}$; $\\text{M(IFN-}\\gamma\\text{+LPS)}$: citrate $\\mathrm{M{+}6}$, malate $\\mathrm{M{+}5}$**\n    This option contains several impossible or highly unlikely isotopologues given the problem's constraints. Citrate $\\mathrm{M{+}2}$ would require unlabeled OAA and labeled acetyl-CoA($\\mathrm{M{+}2}$), but the problem assumes acetyl-CoA is unlabeled. Malate is a $C_4$ dicarboxylate and therefore cannot be malate $\\mathrm{M{+}5}$. Citrate $\\mathrm{M{+}6}$ would require both OAA($\\mathrm{M{+}4}$) and acetyl-CoA($\\mathrm{M{+}2}$), again contradicting the assumption of unlabeled acetyl-CoA. This option is biochemically inconsistent.\n    Verdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2860398"}]}